Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.82%
#3 Ankr Network Ankr Network +20.98%
#4 BankrCoin BankrCoin +19.15%
#5 Status Status +12.73%
#6 Hive Hive +11.15%
#7 Pons Pons +9.35%
#8 Provenance Blockchain Provenance Blockchain +9.19%
#9 Prom Prom +8.82%
#10 Useless Coin Useless Coin +8.39%
Coin of the day
Palladium Network Palladium Network
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Peringkat dalam Saham #18092
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Harga Saham
$10.22
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$212.97M
Perubahan (1 hari)
4.58%
Perubahan (1 tahun)
78.08%
Negara
CA
Perdagangan Satellos Bioscience Inc. (MSCL)

Kategori

Healthcare
Riwayat hasil dividen untuk Satellos Bioscience Inc. (MSCL)
Hasil dividen (TTM) dari Satellos Bioscience Inc. (simbol saham: MSCL) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Satellos Bioscience Inc. (MSCL) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.48%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH